Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes

Lipoprotein (a) [Lp(a)] is a risk factor for coronary artery disease (CAD) and its related phenotypes.

The Clinical Effect Of Arrhythmia Monitoring After Myocardial Infarction (BIO-GUARD-MI): Study Protocol For A Randomized Controlled Trial

Even though the prognosis after myocardial infarction (MI) has improved much over recent decades due to improved and faster revascularization, platelet inhibition, and device therapy, a proportion of post-acute MI (AMI) patients with additional risk factors remain at high risk, with 5-year mortality ranging from 15% to 45% depending on the population.

Prevalence and Risk Factors for Dyslipidemia among Adults in Rural and Urban China: Findings from the China National Stroke Screening and Prevention Project (CNSSPP)

Lipid abnormalities are associated with an increased risk of CV events including coronary heart disease (CHD), thereby serving as contributors to this process.

Multimodality Imaging for Best Dealing with Patients in Atrial Arrhythmias

Atrial fibrillation (AF) is the most common cardiac arrhythmia, with approximately 3% of prevalence in adults, which enhances additionally with advancing age.

Adoption of the Coronary Artery Disease-reporting and Data System: Reduced Downstream Testing and Cardiology Referral Rates in Patients with Non-obstructive Coronary Artery Disease

Coronary CT angiography (CCTA) is well-validated as an initial test in patients without known coronary artery disease (CAD) presenting with acute and stable chest pain.